Group 1 - The core point of the article is that Daotong Technology (SH 688208) held its 27th meeting of the fourth board on October 24, 2025, to review the proposal for the Q3 2025 report [1] - For the year 2024, Daotong Technology's revenue composition is as follows: 76.76% from the automotive electronics sector, 22.04% from the new energy sector, and 1.2% from other businesses [1] - As of the time of reporting, Daotong Technology has a market capitalization of 25.4 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year, highlighting the hot secondary market in biomedicine [1] - A conversation with Lu Gang, a partner at Chuangdong Investment, indicates that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]
道通科技:10月24日召开董事会会议